1.Study on clinical effectiveness of acupuncture and moxibustion on acute Bell's facial paralysis: randomized controlled clinical observation.
Bin WU ; Ning LI ; Yi LIU ; Chang-qiong HUANG ; Yong-ling ZHANG
Chinese Acupuncture & Moxibustion 2006;26(3):157-160
OBJECTIVETo investigate the adverse effects of acupuncture on the prognosis, and effectiveness of acupuncture combined with far infrared ray in the patient of acute Bell's facial paralysis within 48 h.
METHODSClinically randomized controlled trial was used, and the patients were divided into 3 groups: group A (early acupuncture group), group B (acupuncture combined with far infrared ray) and group C (acupuncture after 7 days). The facial nerve functional classification at the attack, 7 days after the attack and after treatment, the clinically cured rate of following-up of 6 months, and the average cured time, the cured time of complete facial paralysis were observed in the 3 groups.
RESULTSThere were no significant differences among the 3 groups in the facial nerve functional classification 7 days after the attack, the clinically cured rate of following-up of 6 months and the average cured time (P > 0.05), but the cured time of complete facial paralysis in the group A and the group B were shorter than that in the group C (P < 0.05).
CONCLUSIONThe patient of acute Bell's facial paralysis can be treated with acupuncture and moxibustion, and traditional moxibustion can be replaced by far infrared way.
Acupuncture Therapy ; Bell Palsy ; therapy ; Facial Paralysis ; therapy ; Humans ; Moxibustion ; Treatment Outcome
2.Observation on therapeutic effect of warming needle moxibustion on knee osteoarthritis of deficiency-cold type.
Chang-du LI ; Xin-yong HUANG ; Xu-guang YANG ; Qiong-fen WANG ; Si-qin HUANG
Chinese Acupuncture & Moxibustion 2006;26(3):189-191
OBJECTIVETo compare clinically therapeutic effects of warming needle moxibustion and simple acupuncture on knee osteoarthritis.
METHODSOne hundred and twenty cases conformed with the diagnostic criteria of knee osteoarthritis with TCM kidney-yang deficiency and cold syndrome were randomly divided into a warming needle moxibustion group and a simple acupuncture group. Guanyuan (CV 4), Qihai (CV 6), Zusanli (ST 36) and others were selected in the two groups. Their therapeutic effects were assessed with joint pain scale, knee osteoarthritis severity index scale and cold syndrome differentiation factors.
RESULTSBoth warming needle moxibustion and simple acupuncture could alleviate pain of knee osteoarthritis, improve dysfunction of the knee joint, reduce symptoms. The clinically basic cured rate and the total effective rate were 32.1% and 96.4% in the warming needle moxibustion group, which were better than 7.4% and 92.6% in the simple acupuncture group.
CONCLUSIONWarming needle moxibustion is an effective therapy for knee osteoarthritis with kidney-yang deficiency and cold type.
Acupuncture Therapy ; Humans ; Moxibustion ; Needles ; Osteoarthritis, Knee ; therapy ; Yang Deficiency
3.Randomized controlled study on AMIE methods for treatment of movement disorder in the child of convulsive cerebral palsy.
Jing HE ; Xiao-Li DONG ; Yu-Hu DUAN ; Hong-Ling ZHOU ; Chang-Qiong HUANG ; Yi LIU ; Yu ZHAO ; Ming-Jin CHEN
Chinese Acupuncture & Moxibustion 2007;27(11):797-800
OBJECTIVETo observe the curative effect of AMIE methods on movement disorder in the child of convulsive cerebral palsy (CP).
METHODSOne hundred and twenty cases of CP children were randomly divided into an integration treatment group and a rehabilitation group, 60 cases in each group. The integration treatment group were treated with acupuncture (A), massage (M), injection (I) and five animal exercise (E) therapies for 60 times, and the rehabilitation group were treated with Bobath training therapy for 60 times. Scores for movement function before and after treatment were used for assessment of therapeutic effect. Twelve months later, understand whether or not the children can walk on ones own.
RESULTSThe total effective rate was 76.70% in the integration treatment group and 58.4% in the rehabilitation group, with no significant difference between the two groups (P > 0.05); there were significant differences in the two groups in differences of movement function scores before and after treatment (P < 0.05). After one year's follow-up survey, 36 children could walk by themselves in the integration treatment group, which were significantly more than 24 children in the rehabilitation group (P < 0.05).
CONCLUSIONAMIE methods is effective for treatment of movement disorder in the child of convulsive cerebral palsy, and the short-term therapeutic effect is same as that of Bobath training method and the long-term therapeutic effect is better than that of Bobath training method.
Acupuncture Points ; Acupuncture Therapy ; methods ; Cerebral Palsy ; therapy ; Child, Preschool ; Combined Modality Therapy ; Female ; Humans ; Infant ; Injections ; Male ; Massage ; Medicine, Chinese Traditional ; Movement Disorders ; therapy
4.Clinical study on combination of acupuncture, cupping and medicine for treatment of fibromyalgia syndrome.
Chang-du LI ; Xiao-ying FU ; Zhen-ya JIANG ; Xu-guang YANG ; Si-qin HUANG ; Qiong-fen WANG ; Jia LIU ; Yuan CHEN
Chinese Acupuncture & Moxibustion 2006;26(1):8-10
OBJECTIVETo observe the therapeutic effect of acupuncture at five mental points and moving cupping on the Hechelu of the back on fibromyalgia syndrome (FS).
METHODSSixty-six cases who conformed to the criteria were randomly divided into the treatment group treated with acupuncture at five mental points, moving cupping on the Hechelu of the back and amitriptyline, and the control group treated with amitriptyline. Clinical therapeutic effects were assessed with McGill Pain Questionnaire (MPQ) and HAMD depression scale.
RESULTSThe therapeutic effect of the treatment group was better than that of the control group with a significant difference between the two groups (P < 0.01).
CONCLUSIONCombination of acupuncture with cupping therapy is an effective therapy for fibromyalgia syndrome.
Acupuncture Points ; Acupuncture Therapy ; Biomedical Research ; Fibromyalgia ; Humans ; Pain Measurement
5.Current status of medical instrument cleaning in 127 hospitals in five coastal provinces or cities in China
zhe Wen ZHOU ; Lei QIN ; guo Sen ZHENG ; Xiao CHANG ; hua Pei ZHANG ; qiong Xiao HUANG ; yan Yan CHEN
Chinese Journal of Nursing 2017;52(11):1361-1365
Objective To investigate the current situation of medical instrument cleaning in Central Sterile Supply Departments(CSSD),in order to identify problems and provide references for further improvements of equipment cleaning.Methods Questionnaire survey was adopted,data of 127 CSSDs in five coastal provinces or cities in China in 2017 were collected,and status of each link of medical instrument cleaning was analyzed.Results The allocation rate of ultrasonic cleaner and spray cleaner were 96.6% and 78.7%,respectively;62.2% of hospitals used tap water to pre-rinse,and 10.2% used normal saline or sterile water to pre-rinse,11.0% used tap water for finial rinsing;78.7% of hospitals did not perform continuous humidification in transit,and 18.1% of hospitals did not perform continuous humidification and their time of transit was more than 2 hours;66.9% of CSSDs only used multi-enzyme detergent.More than half of the hospitals did not record time for manual rinsing/manual final rinsing.Conclusion The configuration of medical instrument cleaning equipment of 127 CSSDs is good.However,it is necessary to pay more attention to cleaning details.Specifications for instrument cleaning water should be established;continuous humidification during transportation of medical instruments should be promoted;cleaning methods and cleaning detergents should be selected reasonably;standardized rinsing should be enhanced to ensure quality of medical instrument cleaning.
6.Effect of erythropoietin on cognitive function in rats with traumatic brain injury
Qiang JIA ; Da-Shi ZHI ; Hui-Ling HUANG ; Qiao-Li WU ; Qiong WANG ; Xue-Bin ZHANG ; Xiao-Li CHANG
Chinese Journal of Neuromedicine 2010;09(7):686-689,696
Objective To evaluate the effect of erythropoietin (EPO) on cognitive function in rats with traumatic brain injury (TBI) and investigate its mechanisms. Methods Forty-eight SD rats were equally randomized into control, sham-operated, TBI and EPO+TBI groups. TBI models were established in the later 2 groups by operation and hydraulic shock. Sham-operated group received the operation only. The EPO+TBI group was injected with EPO immediately after the success of model making; the other groups were injected with saline at the same time. On the 30th d of injury, Morris water maze was employed to evaluate the cognitive function of the rats and the expression of brain-derived growth factor (BDNF) was detected by immunohistochemistry. Results In the navigation experiment, the latent period (the rats on founding the platform) in the control and sham-operated groups was significantly shorter than that in the other 2 groups (P<0.05); that in the TBI group was statistically longer than that in the EPO+TBI group (P<0.05). In the space searching experiment, the swimming times of the rats in each quadrant were significantly different (P<0.05): the control and sham-operated groups were the longest and the TBI group was the shortest of all the 4 groups. Immunohistochemistry showed that the expression of BDNF in the EPO+TBI group was significantly higher than that in the other 3 groups (P< 0.05). Conclusion TBI can damage cognitive function of the rats, while exogenous EPO may improve their memory abilities by up-regulating the expression of BDNF.
7. Bortezomib-based induction chemotherapy followed by autologous hematopoietic stem cell transplantation and maintenance in 200 patients with multiple myeloma: long-term follow-up results from single center
Qiong WU ; Junru LIU ; Beihui HUANG ; Waiyi ZOU ; Jingli GU ; Meilan CHEN ; Lifen KUANG ; Dong ZHENG ; Duorong XU ; Zhenhai ZHOU ; Hehua WANG ; Chang SU ; Xiuzhen TONG ; Juan LI
Chinese Journal of Hematology 2019;40(6):453-459
Objective:
To study the efficacy, safety and long-term outcomes of integrated strategy of bortezomib-based induction regimens followed by autologous hematopoietic stem cell (ASCT) and maintenance therapy in Chinese multiple myeloma (MM) patients.
Methods:
200 MM patients receiving integrated strategy of bortezomib--based induction regimens followed by ASCT and maintenance therapy were retrospectively and prospectively analyzed from December 1. 2006 to April 30. 2018.
Results:
The complete remission rates (CR) and better than very good partial remission rates (VGPR) after induction therapy, transplantation and maintenance therapy were respectively 31% and 75.5%, 51.8% and 87.7%,73.6% and 93.4%. There was no difference between 4 cycles and more than 5 cycles induction chemotherapy. The negative rate of MRD detection by flow cytometry was 17.6% and 38.2% respectively after induction and 3 months after transplantation. The negative rate of MRD gradually increased during the maintenance therapy. The success rate of high dose CTX combined with G-CSF mobilization was 95.5% and transplantation related mortality (TRM) was zero. The median time to progress (TTP) was 75.3 months and the median overall survival (OS) was 99.5 months. TTP of patients obtaining CR and negative MRD after induction were longer that those of no CR and positive MRD. TTP and OS of patients receiving triple-drug induction and ASCT in early stage were longer than those of double-drug induction and ASCT in late stage. LDH≥240 U/L, high risk cytogenetics, ISS II+III stage and HBsAg positive were prognostic factors at diagnosis. However, only MRD and high risk cytogenetics were independent prognostic factors after transplantation and maintenance therapy. The clinical characteristics of patients of TTP ≥6 years were listed below: light-chain type M protein, ISS I stage, normal level of hemoglobin and platelet, normal LDH, HBsAg negative, chromosome 17p-negative, good response and sustained good response.
Conclusions
Integrated strategy of bortezomib-based induction regimens followed by ASCT and maintenance therapy can significantly improve the short-term and long-term efficacy. The prognostic factors of TTP in different disease stages were different. Response to treatment, especially MRD, played a more important role in prognostic factors.
8.Thalassemia screening and genotyping in Southwest Guizhou Autonomous Prefecture of Guizhou Province
Hongmei MURONG ; Xiuxiu ZHANG ; Hua CHANG ; Panpan LI ; Hong ZHAO ; Qiong LI ; Yuting XIANG ; Dachun TANG ; Chan HUANG
Chinese Journal of Endemiology 2022;41(6):444-449
Objective:To analyze the thalassemia screening and genotyping in Southwest Guizhou Autonomous Prefecture (referred it as Qianxinan Prefecture), this essay provides the theoretical reference for clinical diagnosis of thalassemia and suspicious cases.Methods:The pregnant women, spouses and neonates who were screened for thalassemia gene in Qian Xi Nan People's Hospital from January 2016 to December 2020 were selected as the research subjects, and peripheral blood or umbilical cord blood samples were collected to extract DNA. The gap-polymerase chain reaction (Gap-PCR) and next-generation sequencing (NGS) technology were used to screen thalassemia, and ArcMap 10.8 software was adopted to map the local spatial distribution of thalassemia based on the screening data.Results:A total of 67 185 cases of people from various regions in Qianxinan Prefecture were screened, and 8 202 cases of thalassemia gene carriers were detected, with a total detection rate of 12.21%. Among them, 5 660 cases of α-thalassemia, with a detection rate of 8.42%; 2 132 cases of β-thalassemia, with a detection rate of 3.17%; 410 cases of αβ complex thalassemia, with a detection rate of 0.61%. In the detection of thalassemia genes, 27 genotypes of α-thalassemia were detected, mainly αα/-α 3.7, accounting for 41.13% (2 328/5 660); 33 genotypes of β-thalassemia were detected, mainly β CD17(A>T)/β A, accounting for 44.09% (940/2 132); 55 genotypes of αβ complex thalassemia were detected, and αα/-α 3.7 complexed β CD17(A>T)/β A dominated, accounting for 21.22% (87/410). There were high incidence areas in the spatial distribution of thalassemia, which were Wangmo County and Ceheng County, and the detection rate was 26.76% (1 438/5 374), 24.39% (1 314/5 387), respectively. Conclusions:The detection rate of thalassemia gene in Qianxinan Prefecture is relatively high, mainly αα/-α 3.7 genotype of α-thalassemia. Wangmo County and Ceheng County are high-incidence areas of thalassemia, and screening efforts should be continued.
9.Five patients with 11β-hydroxylase deficiency due to CYP11B1 gene mutation: A case study
Haihua YANG ; Yangshiyu LI ; Qiong CHEN ; Ai HUANG ; Chang SU ; Yongxing CHEN ; Haiyan WEI
Chinese Journal of Endocrinology and Metabolism 2023;39(1):34-41
Objective:To investigate the clinical and molecular characteristics of 11β-hydroxylase deficiency(11β-OHD) to improve the understanding of this disorder.Methods:The clinical manifestation, hormone level, imaging examination, characteristics of gene variation and follow-up of five patients with 11β-OHD diagnosed in Henan Children′s Hospital from 2016 to 2021 were carefully reviewed.Results:Among the 5 children, 3 were male and 2 were female, all without positive family history. The age at diagnosis was 1 year 5 months to 7 years(average 3 years and 9 months), and the bone age was 3 years 6 months to 16 years(average 10 years and 3 months). Two cases were misdiagnosed as 21-hydroxylase deficiency(21-OHD) and treated with long-term mineralocorticoids. Three patients presented with hypertension and one patient had testicular adrenal rest tumor. Adrenal CT showed bilateral adrenal hyperplasia in five patients. ACTH, 17-hydroxyprogesterone, testosterone, and androstenedione levels were increased in 5 children, and hypokalemia occurred in 1 patient. One patient carried homozygous novel missense variant, and four patients had compound heterozygous variants. Four patients carried missence mutations, two patients had deletion and one patient harbored a chimeric CYP11B2 exon1-6/CYP11B1 exon7-9. Three novel CYP11B1 mutations, including c. 1385T>C(p.L462P), c.64C>T(p.Q22*)and c. 1354G>A(p.G452R) were identified. The final height of 2 male children were 164.4 cm and 150.2 cm, respectively, and the related hormone levels of the other 3 children were normal.Conclusion:11β-OHD is easily misdiagnosed, leading to severe impairment of final height. CYP11B1 gene variation is complex and diverse, which requires variety of gene detection methods.
10.Bortezomib-based induction chemotherapy followed by autologous hematopoietic stem cell transplantation and maintenance in 200 patients with multiple myeloma: long-term follow-up results from single center.
Qiong WU ; Jun Ru LIU ; Bei Hui HUANG ; Wai Yi ZOU ; Jing Li GU ; Mei Lan CHEN ; Li Fen KUANG ; Dong ZHENG ; Duo Rong XU ; Zhen Hai ZHOU ; He Hua WANG ; Chang SU ; Xiu Zhen TONG ; Juan LI
Chinese Journal of Hematology 2019;40(6):453-459
Objective: To study the efficacy, safety and long-term outcomes of integrated strategy of bortezomib-based induction regimens followed by autologous hematopoietic stem cell (ASCT) and maintenance therapy in Chinese multiple myeloma (MM) patients. Methods: 200 MM patients receiving integrated strategy of bortezomib--based induction regimens followed by ASCT and maintenance therapy were retrospectively and prospectively analyzed from December 1. 2006 to April 30. 2018. Results: The complete remission rates (CR) and better than very good partial remission rates (VGPR) after induction therapy, transplantation and maintenance therapy were respectively 31% and 75.5%, 51.8% and 87.7%,73.6% and 93.4%. There was no difference between 4 cycles and more than 5 cycles induction chemotherapy. The negative rate of MRD detection by flow cytometry was 17.6% and 38.2% respectively after induction and 3 months after transplantation. The negative rate of MRD gradually increased during the maintenance therapy. The success rate of high dose CTX combined with G-CSF mobilization was 95.5% and transplantation related mortality (TRM) was zero. The median time to progress (TTP) was 75.3 months and the median overall survival (OS) was 99.5 months. TTP of patients obtaining CR and negative MRD after induction were longer that those of no CR and positive MRD. TTP and OS of patients receiving triple-drug induction and ASCT in early stage were longer than those of double-drug induction and ASCT in late stage. LDH≥240 U/L, high risk cytogenetics, ISS II+III stage and HBsAg positive were prognostic factors at diagnosis. However, only MRD and high risk cytogenetics were independent prognostic factors after transplantation and maintenance therapy. The clinical characteristics of patients of TTP ≥6 years were listed below: light-chain type M protein, ISS I stage, normal level of hemoglobin and platelet, normal LDH, HBsAg negative, chromosome 17p-negative, good response and sustained good response. Conclusions: Integrated strategy of bortezomib-based induction regimens followed by ASCT and maintenance therapy can significantly improve the short-term and long-term efficacy. The prognostic factors of TTP in different disease stages were different. Response to treatment, especially MRD, played a more important role in prognostic factors.
Antineoplastic Combined Chemotherapy Protocols
;
Bortezomib/therapeutic use*
;
Follow-Up Studies
;
Hematopoietic Stem Cell Transplantation
;
Humans
;
Induction Chemotherapy
;
Multiple Myeloma/therapy*
;
Retrospective Studies
;
Stem Cell Transplantation
;
Transplantation, Autologous
;
Treatment Outcome